300181 佐力药业
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)15.82014.09812.00610.4106.100
总资产报酬率 ROA (%)11.24010.5358.5436.8763.929
投入资产回报率 ROIC (%)13.95912.81410.5058.4104.286

边际利润分析
销售毛利率 (%)61.60668.42470.57071.43267.893
营业利润率 (%)24.64423.10018.68115.43510.080
息税前利润/营业总收入 (%)23.85822.26018.23715.88511.421
净利润/营业总收入 (%)20.90020.11715.81713.1738.737

收益指标分析
经营活动净收益/利润总额(%)87.53681.67981.00778.15172.138
价值变动净收益/利润总额(%)-0.097-0.0230.4570.7740.353
营业外收支净额/利润总额(%)-1.851-0.462-4.040-1.184-0.710

偿债能力分析
流动比率 (X)1.9322.5872.5961.6111.612
速动比率 (X)1.5242.0512.1731.1431.275
资产负债率 (%)31.79323.52024.24027.84430.383
带息债务/全部投入资本 (%)13.2166.6805.6338.263--
股东权益/带息债务 (%)644.4231,367.8241,605.0321,011.120478.227
股东权益/负债合计 (%)211.155319.865306.177240.955213.586
利息保障倍数 (X)-70.591-30.33864.81525.1778.089

营运能力分析
应收账款周转天数 (天)80.82685.78075.06170.6200.000
存货周转天数 (天)155.629218.740200.719205.3720.000